FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20260928E00371
1. Date of relevant event: 22/09/2026
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later): 23/09/2026
(dd/mm/yyyy)
3. Stock code: 01187
4. Name of listed corporation: Cofoe Medical Technology Co., Ltd. - H Shares 
5. Class of shares: A Shares 
6. Number of issued shares in class: 208,897,000
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) ZHANG
(Other names) MIN
10. Name of director (Chinese): 张敏 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1305There has been a change in nature of your interest in the shares because:
you have provided an interest in the shares as security to a person other than a qualified lender
 
2201Interest of corporation controlled by you
 
2201Interest of corporation controlled by you
 		 8,000,000         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position112,795,42454.00
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position112,795,42454.00
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position12,114,881
2202Interest of your spouse
Long position3,485,739
2201Interest of corporation controlled by you
Long position97,194,804
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
Spouse聶娟
Long position100,680,543
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
長沙械字號醫療投資有限公司中國長沙市雨花區振華路199號湖南環保科技產業園創業中心101(546)室張敏90.00Y
Long position85,079,923
長沙械字號醫療投資有限公司中國長沙市雨花區振華路199號湖南環保科技產業園創業中心101(546)室聶娟10.00Y
Long position85,079,923
長沙科源同創創業投資合夥企業(有限合夥)中國長沙市雨花區振華路199號湖南環保科技產業園創業中心101(545)張敏5.00Y
Long position12,114,881
長沙科源同創創業投資合夥企業(有限合夥)中國長沙市雨花區振華路199號湖南環保科技產業園創業中心101(545)聶娟55.00Y
Long position12,114,881
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: 方格29聶娟女士為張敏先生的配偶。長沙械字號醫療投資有限公司("械字號投資")分別由張敏先生及聶娟女士持有90%及10%。張敏先生為長沙科源同創創業投資合夥企業(有限合夥)("長沙科源")的執行事務合夥人及普通合夥人，持有其5%合夥權益；聶娟女士為長沙科源的有限合夥人，持有其55%合夥權益；因此，根據證券及期貨條例，張敏先生及聶娟女士各自被視為在械字號投資持有的85,079,923股A股以及長沙科源持有的12,114,881股A股中擁有權益。方格24械字號投資，於2026年9月22日以中國農業銀行股份有限公司長沙雨花區支行(「質權人」，按照《銀行業條例》(香港法例第155章)界定為認可機構)為受惠人，質押其持有的8,000,000股上市公司A股股份(約佔上市公司已發行股本總額3.39%)，作為其真誠商業貸款的擔保。詳情可參閱上市公司於2026年9月23日發佈的公告。
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 28/09/2026
(dd/mm/yyyy)